MoonLake Immunotherapeutics (MLTX) Insider Trading & Ownership → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MLTX Stock Alerts $42.43 -0.82 (-1.90%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.27%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$68.72 MNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$15.10 M Get MLTX Insider Trade Alerts Want to know when executives and insiders are buying or selling MoonLake Immunotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MLTX Insider Buying and Selling by Quarter Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… MoonLake Immunotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/29/2024Da Silva Jorge SantosCEOSell4,740$55.89$264,918.60 2/27/2024Da Silva Jorge SantosCEOSell62,810$55.00$3,454,550.00 2/27/2024Kristian ReichInsiderSell29,431$55.00$1,618,705.00 2/20/2024Da Silva Jorge SantosCEOSell20,000$57.44$1,148,800.00 2/20/2024Kristian ReichInsiderSell10,000$57.43$574,300.00 2/16/2024Kristian ReichInsiderSell10,000$60.15$601,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/15/2024Da Silva Jorge SantosCEOSell20,000$60.18$1,203,600.00 2/14/2024Kristian ReichInsiderSell10,000$62.43$624,300.00 12/19/2023Matthias BodenstedtCFOSell94,736$59.22$5,610,265.92 10/4/2023Bihua ChenMajor ShareholderBuy67,814$57.32$3,887,098.48 10/2/2023Bihua ChenMajor ShareholderBuy74,911$57.37$4,297,644.07 6/30/2023Bihua ChenMajor ShareholderBuy800,000$50.00$40,000,000.00 6/26/2023Bihua ChenMajor ShareholderBuy450,000$45.63$20,533,500.00 (Data available from 1/1/2013 forward) MLTX Insider Trading Activity - Frequently Asked Questions Who is on MoonLake Immunotherapeutics's Insider Roster? The list of insiders at MoonLake Immunotherapeutics includes Bihua Chen, Da Silva Jorge Santos, Kristian Reich, and Matthias Bodenstedt. Learn more on insiders at MLTX. What percentage of MoonLake Immunotherapeutics stock is owned by insiders? 15.27% of MoonLake Immunotherapeutics stock is owned by insiders. Learn more on MLTX's insider holdings. Which MoonLake Immunotherapeutics insiders have been buying company stock? The following insider purchased MLTX shares in the last 24 months: Bihua Chen ($80,319,331.74). How much insider buying is happening at MoonLake Immunotherapeutics? Insiders have purchased a total of 1,981,314 MLTX shares in the last 24 months for a total of $80,319,331.74 bought. Which MoonLake Immunotherapeutics insiders have been selling company stock? The following insiders have sold MLTX shares in the last 24 months: Da Silva Jorge Santos ($6,071,868.60), Kristian Reich ($3,418,805.00), and Matthias Bodenstedt ($5,610,265.92). How much insider selling is happening at MoonLake Immunotherapeutics? Insiders have sold a total of 261,717 MoonLake Immunotherapeutics shares in the last 24 months for a total of $15,100,939.52 sold. More Insider Trading Tools from MarketBeat Related Companies: ACAD Insider Trading ARWR Insider Trading JANX Insider Trading IDYA Insider Trading SMMT Insider Trading FOLD Insider Trading XENE Insider Trading CORT Insider Trading MRUS Insider Trading BHC Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:MLTX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe Greatest Bull Market in Crypto History…Weiss RatingsNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MoonLake Immunotherapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
